Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,697
Closed -$278K 45
2023
Q3
$278K Sell
2,697
-14
-0.5% -$1.51K 0.13% 68
2023
Q2
$313K Buy
2,711
+40
+1% +$4.54K 0.14% 67
2023
Q1
$284K Buy
2,671
+217
+9% +$23.4K 0.14% 69
2022
Q4
$272K Sell
2,454
-125
-5% -$12.8K 0.14% 71
2022
Q3
$222K Buy
2,579
+15
+0.6% +$1.34K 0.13% 68
2022
Q2
$234K Buy
+2,564
New +$227K 0.13% 68
2021
Q1
Sell
-2,691
Closed -$210K 78
2020
Q4
$210K Hold
2,691
0.13% 73
2020
Q3
$213K Buy
+2,691
New +$211K 0.15% 67
2020
Q2
Sell
-2,768
Closed -$203K 65
2020
Q1
$203K Buy
+2,768
New +$218K 0.2% 52
2019
Q3
Sell
-2,673
Closed -$214K 51
2019
Q2
$214K Buy
+2,673
New +$205K 0.18% 49

Other funds holding MRK

Trellis Advisors's MRK Position: Q4 2023 in Review

Trellis Advisors sold out of Merck (MRK) in Q4 2023, closing a stake of 2,697 shares — an estimated $278K sold.

Trellis Advisors first reported a position in MRK in Q2 2019 and held it in 10 quarters. The position peaked at $313K in Q2 2023. 3,435 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Trellis Advisors reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • Trellis Advisors sold 2,697 Merck shares in Q4 2023, an estimated $278K.
  • Trellis Advisors first reported a position in Merck in Q2 2019 and held it in 10 quarters.
  • Trellis Advisors's Merck position peaked at $313K in Q2 2023.
  • 3,435 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Trellis Advisors's 13F filing for Q4 2023.